-
Prof. Claudio Cuello at McGill University and his collaborators have genetically manipulated rats that can emulate Alzheimer's disease in humans, enabling research that will include the development of new treatments. Alzheimer's is a devastating brain condition leading to a progressive decline of memory and other brain functions......
-
How do we handle the ethical dilemmas of research on adults who can't give their informed consent? In a recent article in the journal Bioethics, ethicist Stefan Eriksson proposes a new approach to the dilemma of including dementia patients and others with limited decision making capabilities in research......
-
By blocking the cellular signaling activity of a protein, a team of neuroscientists at Cold Spring Harbor Laboratory (CSHL) has prevented memory loss in fruit flies caused by brain plaques similar to those thought to cause Alzheimer's disease in humans......
-
It is estimated that Alzheimer's disease affects 5.3 million Americans and that number is expected to double by 2050. Caregivers shoulder a particularly heavy burden as the illness alters the dementia patient's behavior, mood and judgment, impeding his or her ability to engage in normal, everyday activities......
-
Currently, Alzheimer's disease cannot be definitively diagnosed until after death, when a brain autopsy is performed on a patient and evidence of beta-amyloid plaque deposits in the brain - which are a characteristic pathology of the disease - can be found......
-
Alistair Darling's budget speech In his budget speech, Alistair Darling announced that the government will shortly be setting out its long-term plans for social care reform as well as the steps needed in the next parliament to move towards this goal. Alzheimer's Society comment: 'Today's budget shows a commitment from ...
-
Among seniors, women and patients with diabetes and dementia are the most likely to fall into the Medicare Part D prescription drug plan "donut hole" - the gap occurring after beneficiaries reach their annual coverage limit and before catastrophic coverage kicks in - according to new research published online in ...
-
A new test developed by Japanese scientists may revolutionize how and when physicians diagnose Alzheimer's disease. According to a research report published online in The FASEB Journal, the new test measures proteins in the spinal fluid known to be one of the main causes of brain degeneration and memory impairment ...
-
Dr. MarÃa Angeles Mena, Researcher at Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED) and Director of the Neuropharmacology Laboratory at Hospital Ramón y Cajal (Madrid, Spain), coordinated the study performed by predoctoral student Juan Perucho and others......
-
Health care environments for people with dementia are set to be improved as part of the next phase of The King's Fund's Enhancing the Healing Environment (EHE) programme. Chief Nursing Officer Dame Christine Beasley announced the 12 NHS trusts which will each receive a project grant from the Department of ...
-
Dr. Maria Angeles Mena, Researcher at Centro de Investigacion Biomedica en Red de Enfermedades Neurodegenerativas (CIBERNED) and Director of the Neuropharmacology Laboratory at Hospital Ramon y Cajal (Madrid, Spain), coordinated the study performed by predoctoral student Juan Perucho and others......
-
A study of the brains of people who stayed mentally sharp into their 80s and beyond challenges the notion that brain changes linked to mental decline and Alzheimer's disease are a normal, inevitable part of aging. In a presentation at the 239th National Meeting of the American Chemical Society (ACS), ...
-
Gustavo C. Román, M.D., an internationally recognized expert in vascular dementia, joins the Methodist Neurological Institute (NI) to continue the quest to find a cure for Alzheimer's, a disease diagnosed in the United States every 72 seconds. Román will hold a distinguished endowed chair and lead the Methodist Alzheimer's Disease ...
-
As the leading care, research and advocacy organization for Alzheimer's disease, the Alzheimer's Association applauds Congress for including significant provisions in the final healthcare reform legislation to address the health concerns of a growing Alzheimer population......
-
Memory and thinking skills may decline rapidly for people who have mild cognitive impairment, which is the stage before Alzheimer's disease when people have mild memory problems but no dementia symptoms, and even more rapidly when dementia begins, which is when Alzheimer's disease is usually diagnosed......
-
People with Alzheimer's disease experience a rate of cognitive decline four times greater than those with no cognitive impairment according to a new study by researchers at Rush University Medical Center in Chicago......
-
Microglia are the cells responsible for immune surveillance in the brain, and they initiate protective inflammatory reactions in response to tissue damage and infection. An international team under the leadership of LMU neuroscientist Professor Jochen Herms has now shown that these cells may actually make a significant contribution to the ...
-
In today's media there are reports that the government is planning to shelve plans for a new settlement on care and support for older people. It has been suggested that the government will propose working towards a new settlement on care in the next parliament for fear of a backlash ...
-
Dr. Stephen Wong has received a $5 million gift from the Ting Tsung and Wei Fong Chao Foundation to study progressive neurodegenerative diseases including Alzheimer's Disease. The gift will support The Ting Tsung and Wei Fong Chao Center for Bioinformatics Research and Imaging for Neurosciences (BRAIN) at The Methodist Hospital ...
-
Westside Medical Associates of Los Angeles and Westside Medical Imaging (WMI) of Beverly Hills announce the benefit of early positron emission tomography (PET) scanning to identify Alzheimer's in its early more treatable phase. According to Dr......
